CN105770366A - Traditional Chinese medicine composition for treating vitiligo - Google Patents
Traditional Chinese medicine composition for treating vitiligo Download PDFInfo
- Publication number
- CN105770366A CN105770366A CN201610254369.4A CN201610254369A CN105770366A CN 105770366 A CN105770366 A CN 105770366A CN 201610254369 A CN201610254369 A CN 201610254369A CN 105770366 A CN105770366 A CN 105770366A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating vitiligo. The traditional Chinese medicine composition comprises the traditional Chinese medicine raw materials in parts by weight: 10-30 parts of herba hedyotis diffusae, 10-20 parts of herba ecliptae, 5-15 parts of flos carthami, 10-20 parts of fructus cnidii, 10-20 parts of herba portulacae, 10-20 parts of impatiens balsamina, 5-15 parts of fructus mume, 10-20 parts of ossa sepiae, 10-20 parts of radix arnebiae, 10-20 parts of radix polygoni multiflori preparata, 5-15 parts of radix saposhnikoviae, 10-20 parts of cassia twig, 10-20 parts of cortex dictamni, 5-15 parts of fructus rubi, 10-20 parts of cacumen biotae, 10-20 parts of herba spirodelae, 5-15 parts of fructus kochiae, 10-20 parts of rhizoma anemarrhenae, 10-20 parts of fiveleaf akebia fruit, 5-15 parts of radix angelicae pubescentis, 10-20 parts of codonopsis pilosula, 10-20 parts of herba menthae and 5-15 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the effects of relieving the decompressed liver, clearing heat and toxins, nourishing and activating blood, dispelling wind and arresting itching, and is remarkable in curative effect on vitiligo, reliable in effect and free of toxic or side effects.
Description
Technical field
The present invention relates to the medicinal preparation not determining structure of a kind of traditional herbal medicines, especially one and treat leukodermic Chinese medicine composition.
Background technology
Vitiligo is a kind of common posteriority limit office's property or general property skin pigment depigmentation disease.Disappeared by the melanocyte function of skin and cause, but mechanism is not clear.The each position of whole body can occur, and is common in the finger back of the body, wrist, forearm, face, neck and surrounding genital etc..Pathological changes is apt to occur in is irradiated and damage by friction position by sunlight, and how symmetrical disease damage is.Female genitalia also can occur, and young women is in the majority.Skin lesion is depigmentation speckle, is often milky, it is possible to for lightpink, smooth surface is without erythra.White macula boundary understands, edge pigment compared with normal skin increases, and in white macula, hair is normal or bleaches.At present, clinical treatment vitiligo is most commonly that the painless melanocyte of GX-B cultivates therapy, and little area skin lesion therapeutic effect is good, but easily recurs, and spends height.
Chinese medicine is thought, vitiligo is many feels ailment said due to cold or exposure again because of internal injury caused by excess of seven emotions, depression of liver-QI, functional activity of QI being not smooth, and obstruction of meridian forms；Or owing to natural endowment is not enough, caused by liver and kidney deficiency, deficient qi and blood, it is impossible to nourish skin and make toxin build up with the passing of time to send out and formed in body surface.
According to theory of Chinese medical science, for leukodermic pathogeny, with dispersing the stagnated live-QI to relieve the stagnation of QI, consolidate and dispel the wind as the rule for the treatment of, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the configuration therapy for treating vitiligo of melanocyte in prior art to exist costly, the deficiency of easily recurrence, the present invention provide a kind of prepare conveniently, medicine source is wide, low cost, evident in efficacy, reliable effect, the leukodermic Chinese medicine composition for the treatment of having no side effect.
nullThe technical solution adopted for the present invention to solve the technical problems is: one treats leukodermic Chinese medicine composition，It is characterized in that: its raw material of Chinese medicine and weight be: Herba Hedyotidis Diffusae 10-30 part，Herba Ecliptae 10-20 part，Flos Carthami 5-15 part，Fructus Cnidii 10-20 part，Herba Portulacae 10-20 part，Flos Impatientis 10-20 part，Fructus Mume 5-15 part，Endoconcha Sepiae 10-20 part，Radix Arnebiae (Radix Lithospermi) 10-20 part，Radix Polygoni Multiflori Preparata 10-20 part，Radix Saposhnikoviae 5-15 part，Ramulus Cinnamomi 10-20 part，Cortex Dictamni 10-20 part，Fructus Rubi 5-15 part，Cacumen Platycladi 10-20 part，Herba Spirodelae 10-20 part，Fructus Kochiae 5-15 part，Rhizoma Anemarrhenae 10-20 part，Fructus Akebiae 10-20 part，Radix Angelicae Pubescentis 5-15 part，Radix Codonopsis 10-20 part，Herba Menthae 10-20 part，Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: one treats leukodermic Chinese medicine composition, it is characterised in that: its raw material of Chinese medicine and weight be: Herba Hedyotidis Diffusae 20 parts, Herba Ecliptae 15 parts, 10 parts of Flos Carthami, Fructus Cnidii 15 parts, Herba Portulacae 15 parts, Flos Impatientis 15 parts, Fructus Mume 10 parts, Endoconcha Sepiae 15 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, Radix Polygoni Multiflori Preparata 15 parts, Radix Saposhnikoviae 10 parts, Ramulus Cinnamomi 15 parts, Cortex Dictamni 15 parts, Fructus Rubi 10 parts, Cacumen Platycladi 15 parts, 15 parts of Herba Spirodelae, the Fructus Kochiae 10 parts, the Rhizoma Anemarrhenae 15 parts, Fructus Akebiae 15 parts, Radix Angelicae Pubescentis 10 parts, Radix Codonopsis 15 parts, Herba Menthae 15 parts, 10 parts of Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Herba Hedyotidis Diffusae has effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain；Herba Ecliptae has effect of liver-nourishing kidney-boosting, cooling blood for hemostasis；Flos Carthami has effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain；Fructus Cnidii has effect of warming the kidney to invigorate YANG, expelling wind and cold, removing dampness and killing parasites；Herba Portulacae has heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery, effect that dehumidifying is treating stranguria；Flos Impatientis has expelling wind and removing dampness, promoting blood circulation and stopping pain, effect of removing toxic substances parasite killing；Fructus Mume has effect of warming middle-JIAO of astringing the lung, relieving diarrhea with astringents, promoting the production of body fluid to quench thirst；Endoconcha Sepiae has astringing to arrest bleeding, treating spontaneous emission and leukorrhagia, relieving gastric hyperacidity to alleviate stomachache, effect of removing dampness sore；Radix Arnebiae (Radix Lithospermi) has clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, effect of removing toxic substances rash；Radix Polygoni Multiflori Preparata has invigorating the liver and kidney, benefiting essence-blood, crow beard and hair, effect of bone and muscle strengthening；Effect that Radix Saposhnikoviae has expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion are jerked surely；Ramulus Cinnamomi has diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, effect of dispersing cold for relieving pain；Cortex Dictamni has heat clearing and damp drying, the effect of removing toxic substances of dispeling the wind；Fructus Rubi has the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, effect of supporing yang improving eyesight；Cacumen Platycladi has cooling blood for hemostasis, eliminating phlegm and stopping cough, wind-damp dispelling, effect of scattered toxic swelling；Herba Spirodelae has that relieving the exterior syndrome by diaphoresis, rash be antipruritic, effect of inducing diuresis to remove edema, heat-clearing and toxic substances removing；The Fructus Kochiae has clearing away heat-damp and promoting diuresis, effect of dispelling wind for relieving itching；The Rhizoma Anemarrhenae has clearing away heat-fire, effect moisturized of promoting the production of body fluid；Fructus Akebiae has liver-smoothing, qi-regulating, promoting blood circulation and stopping pain, effect of relieving restlessness diuresis；Radix Angelicae Pubescentis has effect of expelling wind and dampness, dispersing cold for relieving pain；Radix Codonopsis has effect of invigorating the spleen and replenishing QI, strengthening spleen and tonifying lung；Herba Menthae has dispelling wind and heat pathogens, clear profit removing toxic substances, effect of dispersing the stagnated live-QI to relieve the stagnation of QI；Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.Drug component in the present composition, through dialectical compatibility, complements each other using, and has synergism, plays effect of dispersing the stagnated live-QI to relieve the stagnation of QI, heat-clearing and toxic substances removing, nourshing blood and promoting blood circulation, dispelling wind for relieving itching altogether, and vitiligo reaches the purpose for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all uses natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, low cost.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug use the use that is decocted in water for oral dose.Verifying by clinic application, it is evident in efficacy, reliable effect, mild in medicine property and, toxic and side effects does not occurs, total effective rate 86%, cure rate reaches 50%.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment
1
One treats leukodermic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Herba Hedyotidis Diffusae 20g, Herba Ecliptae 15g, Flos Carthami 10g, Fructus Cnidii 15g, Herba Portulacae 15g, Flos Impatientis 15g, Fructus Mume 10g, Endoconcha Sepiae 15g, Radix Arnebiae (Radix Lithospermi) 15g, Radix Polygoni Multiflori Preparata 15g, Radix Saposhnikoviae 10g, Ramulus Cinnamomi 15g, Cortex Dictamni 15g, Fructus Rubi 10g, Cacumen Platycladi 15g, Herba Spirodelae 15g, Fructus Kochiae 10g, Rhizoma Anemarrhenae 15g, Fructus Akebiae 15g, Radix Angelicae Pubescentis 10g, Radix Codonopsis 15g, Herba Menthae 15g, Radix Glycyrrhizae 10g.
Embodiment
2
One treats leukodermic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Herba Hedyotidis Diffusae 10g, Herba Ecliptae 20g, Flos Carthami 5g, Fructus Cnidii 20g, Herba Portulacae 10g, Flos Impatientis 20g, Fructus Mume 5g, Endoconcha Sepiae 20g, Radix Arnebiae (Radix Lithospermi) 10g, Radix Polygoni Multiflori Preparata 20g, Radix Saposhnikoviae 5g, Ramulus Cinnamomi 20g, Cortex Dictamni 10g, Fructus Rubi 15g, Cacumen Platycladi 10g, Herba Spirodelae 20g, Fructus Kochiae 5g, Rhizoma Anemarrhenae 20g, Fructus Akebiae 10g, Radix Angelicae Pubescentis 15g, Radix Codonopsis 10g, Herba Menthae 20g, Radix Glycyrrhizae 5g.
Embodiment
3
One treats leukodermic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Herba Hedyotidis Diffusae 30g, Herba Ecliptae 10g, Flos Carthami 15g, Fructus Cnidii 10g, Herba Portulacae 20g, Flos Impatientis 10g, Fructus Mume 15g, Endoconcha Sepiae 10g, Radix Arnebiae (Radix Lithospermi) 20g, Radix Polygoni Multiflori Preparata 10g, Radix Saposhnikoviae 15g, Ramulus Cinnamomi 10g, Cortex Dictamni 20g, Fructus Rubi 5g, Cacumen Platycladi 20g, Herba Spirodelae 10g, Fructus Kochiae 15g, Rhizoma Anemarrhenae 10g, Fructus Akebiae 20g, Radix Angelicae Pubescentis 5g, Radix Codonopsis 20g, Herba Menthae 10g, Radix Glycyrrhizae 15g.
Embodiment
4
One treats leukodermic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Herba Hedyotidis Diffusae 15g, Herba Ecliptae 18g, Flos Carthami 8g, Fructus Cnidii 18g, Herba Portulacae 12g, Flos Impatientis 18g, Fructus Mume 8g, Endoconcha Sepiae 18g, Radix Arnebiae (Radix Lithospermi) 12g, Radix Polygoni Multiflori Preparata 18g, Radix Saposhnikoviae 8g, Ramulus Cinnamomi 18g, Cortex Dictamni 12g, Fructus Rubi 13g, Cacumen Platycladi 12g, Herba Spirodelae 18g, Fructus Kochiae 8g, Rhizoma Anemarrhenae 18g, Fructus Akebiae 12g, Radix Angelicae Pubescentis 13g, Radix Codonopsis 12g, Herba Menthae 18g, Radix Glycyrrhizae 8g.
Embodiment
5
One treats leukodermic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Herba Hedyotidis Diffusae 25g, Herba Ecliptae 12g, Flos Carthami 13g, Fructus Cnidii 12g, Herba Portulacae 18g, Flos Impatientis 12g, Fructus Mume 13g, Endoconcha Sepiae 12g, Radix Arnebiae (Radix Lithospermi) 18g, Radix Polygoni Multiflori Preparata 12g, Radix Saposhnikoviae 13g, Ramulus Cinnamomi 12g, Cortex Dictamni 18g, Fructus Rubi 8g, Cacumen Platycladi 18g, Herba Spirodelae 12g, Fructus Kochiae 13g, Rhizoma Anemarrhenae 12g, Fructus Akebiae 18g, Radix Angelicae Pubescentis 8g, Radix Codonopsis 18g, Herba Menthae 12g, Radix Glycyrrhizae 13g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: put in container by the raw material of Chinese medicine of prescription, adds cold water and covers powder, soak 15～20 minutes, added water no powder about 8 centimetres, carries out decocting for the first time, at a simmer before use intense fire to decoct, with slow fire boiling 20～30 minutes after boiling；Second time decocts, and added water no powder about 6 centimetres, decocts 15～20 minutes after water boiling.Twice decoction is removed slag extracting juice, merges.
The present invention treats leukodermic Chinese medicine composition with the one given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: Chinese medicine composition of the present invention is applied to clinical observation case 78 example, the maleest 41 examples, female 37 example, age 12～70 years old.The shortest person of the course of disease 3 months, elder reach 3 years, average 1 year.
Two, diagnostic criteria:
1, skin lesion color bleaches, or speckle or point, and shape differs, without sufferings；
2, can occur at health everywhere, common with extremity, head；
3, feelings will internal injury it is more common in young；
4, tissue pathology checking shows that epidermis substantially lacks melanocyte and melanin granule；Basal layer is often complete lack of the melanocyte that dopa stain is positive.
Three, usage and dosage: during clinical practice, one day potion, decocting twice extracting juice about 400ml, point early, late twice warm is taken, and within five days, is a course for the treatment of.
Four, criterion of therapeutical effect:
1, curing: white macula is wholly absent, the colour of skin recovers normal；
2, take a turn for the better: in white macula disappearance more than 30%, or decolouring speckle, coloured vegetarian refreshments generates；
3, do not heal: unchanged or white macula expansion before and after treatment.
Five, therapeutic effect: in this clinical observation case, take medicine 3-15 the course for the treatment of, cure 39 examples, take a turn for the better 28 examples, the most 11 examples.Toxic and side effects is there is not during treatment.
Six, model case:
Case 1: grandson, female, 18 years old.Being creamy white at the skin lesion depigmentation of wrist back time medical, area is unitary coin-size.After 6 courses for the treatment of of medicament taking prepared by the Chinese medicine composition of the present invention, white macula is wholly absent, and the colour of skin recovers normal, cures.
Case 2: Wang, man, 57 years old, ear rear extend to cervical region forward to front neck have bending bar shaped white macula, clear-cut margin, white macula does not has pigment regeneration phenomenon, accept melanocyte cultivate, after one month recur.After 4 courses for the treatment of of medicament taking prepared by the Chinese medicine composition of the present invention, white spot area is substantially reduced；Continuous take 4 courses for the treatment of after, white spot area disappears more than 95%, only remaining thumbnail area skin lesion；After continuing to take 2 courses for the treatment of, white macula is wholly absent, and cures.
Claims (2)
1. treat leukodermic Chinese medicine composition for one kind, it is characterized in that: its raw material of Chinese medicine and weight be: Herba Hedyotidis Diffusae 10-30 part, Herba Ecliptae 10-20 part, Flos Carthami 5-15 part, Fructus Cnidii 10-20 part, Herba Portulacae 10-20 part, Flos Impatientis 10-20 part, Fructus Mume 5-15 part, Endoconcha Sepiae 10-20 part, Radix Arnebiae (Radix Lithospermi) 10-20 part, Radix Polygoni Multiflori Preparata 10-20 part, Radix Saposhnikoviae 5-15 part, Ramulus Cinnamomi 10-20 part, Cortex Dictamni 10-20 part, Fructus Rubi 5-15 part, Cacumen Platycladi 10-20 part, Herba Spirodelae 10-20 part, Fructus Kochiae 5-15 part, Rhizoma Anemarrhenae 10-20 part, Fructus Akebiae 10-20 part, Radix Angelicae Pubescentis 5-15 part, Radix Codonopsis 10-20 part, Herba Menthae 10-20 part, Radix Glycyrrhizae 5-15 part.
One the most according to claim 1 treats leukodermic Chinese medicine composition, it is characterised in that: its raw material of Chinese medicine and weight be: Herba Hedyotidis Diffusae 20 parts, Herba Ecliptae 15 parts, 10 parts of Flos Carthami, Fructus Cnidii 15 parts, Herba Portulacae 15 parts, Flos Impatientis 15 parts, Fructus Mume 10 parts, Endoconcha Sepiae 15 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, Radix Polygoni Multiflori Preparata 15 parts, Radix Saposhnikoviae 10 parts, Ramulus Cinnamomi 15 parts, Cortex Dictamni 15 parts, Fructus Rubi 10 parts, Cacumen Platycladi 15 parts, 15 parts of Herba Spirodelae, the Fructus Kochiae 10 parts, the Rhizoma Anemarrhenae 15 parts, Fructus Akebiae 15 parts, Radix Angelicae Pubescentis 10 parts, Radix Codonopsis 15 parts, Herba Menthae 15 parts, 10 parts of Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610254369.4A CN105770366A (en) | 2016-04-24 | 2016-04-24 | Traditional Chinese medicine composition for treating vitiligo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610254369.4A CN105770366A (en) | 2016-04-24 | 2016-04-24 | Traditional Chinese medicine composition for treating vitiligo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105770366A true CN105770366A (en) | 2016-07-20 |
Family
ID=56398241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610254369.4A Pending CN105770366A (en) | 2016-04-24 | 2016-04-24 | Traditional Chinese medicine composition for treating vitiligo |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105770366A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1853695A (en) * | 2005-04-29 | 2006-11-01 | 林长喜 | Chinese medicine for treating leucoderma and preparation thereof |
| CN101574431A (en) * | 2009-06-17 | 2009-11-11 | 赵富刚 | Drug for treating vitligo |
| CN101716324A (en) * | 2010-01-07 | 2010-06-02 | 王华柱 | Traditional Chinese medicine pill for treating leucoderma disease |
| CN102430097A (en) * | 2011-11-29 | 2012-05-02 | 渠淑敏 | Chinese medicine for treating vitiligo |
-
2016
- 2016-04-24 CN CN201610254369.4A patent/CN105770366A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1853695A (en) * | 2005-04-29 | 2006-11-01 | 林长喜 | Chinese medicine for treating leucoderma and preparation thereof |
| CN101574431A (en) * | 2009-06-17 | 2009-11-11 | 赵富刚 | Drug for treating vitligo |
| CN101716324A (en) * | 2010-01-07 | 2010-06-02 | 王华柱 | Traditional Chinese medicine pill for treating leucoderma disease |
| CN102430097A (en) * | 2011-11-29 | 2012-05-02 | 渠淑敏 | Chinese medicine for treating vitiligo |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102406821B (en) | Traditional Chinese medicine for treating simple goiter | |
| CN101637512B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN101491653B (en) | Traditional Chinese medicine composite for treating rosacea and use method thereof | |
| CN102784266B (en) | Traditional Chinese medicine composition for treating chloasma | |
| CN103223048B (en) | Traditional Chinese medicine composition for treating facial leukoderma | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN103705898A (en) | Traditional Chinese medicine composition for treating acnes | |
| CN105770366A (en) | Traditional Chinese medicine composition for treating vitiligo | |
| CN104587385A (en) | Traditional Chinese medicine composition for treating blood stasis condensation type rosacea | |
| CN102836405B (en) | Medicament for treating encephaloma | |
| CN105770427A (en) | Traditional Chinese medicine composition for treating oligospermia and asthenozoospermia | |
| CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
| CN106075137A (en) | A kind of Chinese medicine composition treating hysteria | |
| CN105687665A (en) | Traditional Chinese medicine composition for treating acne | |
| CN105687460A (en) | Traditional Chinese medicine composition for treating acne | |
| CN105878555A (en) | Traditional Chinese medicine composition for treating leucoderma | |
| CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN104689175A (en) | Traditional Chinese medicine composition for treating acne | |
| CN103251852A (en) | Medicine for treating osteoarthritis by matching with ultramicro-cutter | |
| CN103948764A (en) | Traditional Chinese medicine for treating edema during menstruation | |
| CN105902907A (en) | Traditional Chinese medicinal composition for treating rosacea | |
| CN105902823A (en) | Traditional Chinese medicine composition for treating chloasma | |
| CN103071077A (en) | Traditional Chinese medicine composition for treating rheumatoid diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160720 |
|
| WD01 | Invention patent application deemed withdrawn after publication |